Radiotherapy Facilities Market in Japan: Key Research Findings 2020
Yano Research Institute (the President, Takashi Mizukoshi) has conducted the domestic radiotherapy facilities market and has found out the transition of the market, trends of radiotherapy facilities as well as the makers, and future outlook. This paper clarifies the result of the updated research on therapeutic instruments at radiotherapy facilities.
According to the material at National Cancer Center, cancer incidents was recorded as 1,017,200 cases in 2019, and is expected to be on the rise to 1,083,590 cases from 2020 to 2024. This seems to stem from rise of people taking cancer screening, and from early detection and treatment of cancer due to improved performance of cancer screening.
Radiotherapy Instruments Market Supported Mainly by Replacement, but Replacement Rate Remained at 40%
Regarding the number of radiotherapy and peripheral instruments which was found out as 233 units by the last research that had taken place from October to November 2016, the follow-up survey was conducted between January and February 2020 and found out the number of instruments replaced to be 88 units (37.8%), indicating that the rest of 145 units (62.2%) was still being used.
The responses to the mailed questionnaire during the same period regarding the radiotherapy facilities showed some challenges, such as “no increase in the number of patients can be expected,” and “shortage in the specialized staff,” which seemed to have affected the belated replacement of radiotherapy instruments.
As the measures against cancer by the government, “3rd-Term Basic Plan for Measures against Cancer” has been in progress since 2018, stipulating to provide wealth of cancer treatments that are not only cancer genome medicine but also surgical treatment, radiotherapy, chemotherapy, and immunotherapy. For radiotherapy, providing of enough ion beam radiation therapy, extensive employment of palliative radiotherapy, equal accessibility to radiotherapy, and cross-prefectural network system, and human resources development including medical physicians were listed in the Plan.
Increase of cancer incidents is likely to drive extensive use of palliative radiotherapy, interaction of molecular target drugs and cancer genome medicine, and cross-prefectural network system to be built, which is expected to continuously expand the radiotherapy market size.
The copyright and all other rights pertaining to this report belong to Yano Research Institute.
Please contact our PR team when quoting the report contents for the purpose other than media coverage.
Depending on the purpose of using our report, we may ask you to present your sentences for confirmation beforehand.